We suggest that the consequences of disrupting CRMP2 expression include glucose intolerance and obesity due to the inefficient glucose uptake but excess lipid synthesis and accumulation, which eventually would lead to the development of insulin resistance and diabetic onset. Here, DPYSL2 is linked to Glucose intolerance.